The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose

Bone Marrow Transplantation

Volumn 25, Issue 4, 2000, Pages 435-440

  Stewart, D A ^a,c   Guo, D ^b   Luider, J ^b   Auer, I ^b   Klassen, J ^b   Morris, D ^a   Chaudhry, A ^a   Brown, C ^a   Russell, J A ^a   Gluck, S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Hematopoietic stem cell transplantation; Hematopoietic stem cells

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FIBRINOGEN RECEPTOR; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; MITOXANTRONE; THY 1 ANTIGEN;

ADULT; AGED; APHERESIS; ARTICLE; BREAST CANCER; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0033994523     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702171     Document Type: Article

References (29)

1. To LB, Haylock DN, Simmons PJ et al. The biology and clinical use of blood stem cells. Blood 1997; 89: 2233-2258.
2. + cell determination by flow cytometry. J Hematother 1996; 5: 213-226.
3. + analysis may be used to guide peripheral-blood stem cell harvest. Bone Marrow Transplant 1995; 9: 439-444.
4. Krause DS, Fackler MJ, Civin CI et al. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
5. + hematopoietic cells from human bone marrow. J Exp Med 1990; 172: 363-366.
6. Terstappen LWMM, Huang S, Safford M et al. Sequential generation of hematopoietic colonies derived from single non-lineage-committed CD34+38- progenitor cells. Blood 1991; 77: 1218-1227.
7. Bernstein ID, Leary AG, Andrews RG et al. Blast colony-forming cells and precursors of colony-forming cells detectable in long-term marrow culture express the same phenotype (CD33-CD34+). Exp Hematol 1991; 19: 680-682.
8. + hematopoietic progenitor cells. Br J Haematol 1994; 84: 24-30.
9. Brandt J, Baird N, Lu L et al. Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest 1988; 82: 1017-1027.
10. Buhring HJ, Asenbauer B, Katrilaka K et al. Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells. Eur J Haematol 1989; 42: 143-149.
11. Loken MR, Shah VO, Dattilio KL et al. Flow cytometric analysis of human bone marrow. I. Normal erythroid development. Blood 1987; 69: 255-263.
12. Loken MR, Shah VO, Dattilio KL et al. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316-1324.
13. Debili N, Issaad C, Masse JM et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992; 80: 3022-3035.
14. Vainchenker W, Deschamps JF, Bastin JM et al. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. Blood 1982; 59: 514-521.
15. + cell dose. Bone Marrow Transplant 1999; 23: 1237-1243.
16. + cells and rapid hematopoietic recovery after peripheral-blood stem cell transplantation. J Clin Oncol 1995; 13: 1922-1932.
17. +/CD33 cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue. Bone Marrow Transplant 1998; 22: 469-475.
18. Copelan EA, Ceselski SK, Ezzone SA et al. Mobilization of peripheral-blood progenitor cells with high dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma. and Hodgkin's disease. J Clin Oncol 1997; 15: 759-765.
19. Pecora AL, Preti RA, Gleim GW et al. CD34+33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients. J Clin Oncol 1998; 16: 2093-2104.
20. Gonzalez-Requejo A, Madero L, Diaz MA et al. Progenitor cell subsets and engraftemnt kinetics in children undergoing autologous peripheral blood stem cell transplantation. Br J Haematol 1998; 101: 104-110.
21. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
22. Humeau L, Bardin F, Maroc C et al. Phenotypic, molecular and functional characterisation of human peripheral blood CD34+/Thy1+ cells. Blood 1996; 87: 949-955.
23. Haas R, Mohle R, Murea S et al. Characterisation of peripheral blood progenitor cells mobilised by cytotoxic chemotherapy and recombinant granulocyte colony-stimulating factor. J Hematother 1994; 3: 323-330.
24. Murray L, Chen B, Galy A et al. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. Blood 1995; 85: 368-378.
25. Stewart AK, Keating IA, Anania S et al. Optimising the CD34+ and Thy-1+ stem cell content of peripheral blood collections. Exp Hematol 1995; 23: 1619-1627.
26. Tsuchiya S, Kikuta A, Shimizu Y et al. Decrease in Thy-1 expression on peripheral CD34 positive cells induced by G-CSF mobilization. The Tohoku Children Leukemia Study Group. Tohoku J Exp Med 1997; 182: 157-162.
27. Stewart DA, Guo D, Morris D et al. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone Marrow Transplant 1999; 23: 111-117.
28. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheralblood stem cells. J Clin Oncol 1995; 13: 2547-2555.
29. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral-blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 10: 3961-3969.